October 10, 2023
1 min read
Source/Disclosures
Published by:
Disclosures:
Volberding reports no relevant financial disclosures.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
”
data-action=”subscribe”>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Back to Healio
Key takeaways:
- IDWeek is being held in Boston from Oct. 11 to 15.
- Attendees are no longer required to wear a mask or provide proof of COVID-19 vaccination.
IDWeek relaxed its COVID-19 policies this year, no longer requiring that attendees wear a mask or provide proof of vaccination.
Healio will be on site covering the meeting live from Oct. 11 to 15 at the Boston Convention and Exhibition Center.
Last year, attendees were required to wear a mask and verify their COVID-19 vaccination status for the first in-person IDWeek since before the pandemic.
“While vaccination is no longer mandatory, IDWeek strongly encourages all attendees, employees of partner societies, vendors and guests to consider getting vaccinated to contribute to the overall health and well-being of themselves, their colleagues, and the community,” organizers said before this year’s meeting. “These considerations are in alignment with CDC recommendations.”
Additionally, organizers said they “strongly support individual decisions to mask and practice hand hygiene protocols.”
“We are clearly still recovering from the COVID-19 pandemic, but in many respects, it feels as if we have turned a corner, even in the past year,” said Healio | Infectious Disease News Chief Medical Editor Paul A. Volberding, MD, professor emeritus of medicine at the University of California, San Francisco.
IDWeek is an opportunity to “hear how the infectious diseases specialty has continued to take on new challenges,” Volberding told Healio.
“The mRNA technology, recently recognized with a Nobel Prize, is certainly holding the potential for newer vaccines, and the explosion of interest in manipulating large databases — including the use of artificial intelligence — should revolutionize the management of patients with complex infections as we optimize antibiotic choices in the face of resistance mutations and new antibiotic drugs,” Volberding said.
“ID Week will again bring thousands together, this time in Boston, to consider new developments and to reengage with our mission to improve the prevention and treatment of human pathogens. We look forward to sharing the progress we know we will gain!”
Click here to review more than a decade of Healio’s coverage of IDWeek.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
”
data-action=”subscribe”>
Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Back to Healio
